Krystal Biotech Inc (KRYS)

Finanzdaten der Krystal Biotech Inc-Aktie (KRYS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	6.81%127.34	119.22	116.36	107.11	97.80
	7.58%56.20	60.81	62.67	62.84	56.43
Selling, General, and Administrative	15.31%33.75	39.85	41.01	41.45	37.58
Research and Development	2.57%14.89	14.52	15.33	14.79	14.59
Operating Income/Loss	21.79%71.15	58.42	53.69	44.27	41.37
Income/Loss From Continuing Operations Before Tax	21.29%80.15	66.08	61.44	51.13	47.97
Income Tax Expense/Benefit	50.98%17.08	11.31	5.51	-0.27	-31.40
	15.15%63.07	54.77	55.93	51.40	79.37
Attributable To Parent	15.15%63.07	54.77	55.93	51.40	79.37
Basic Average Shares	0.27%29.61	29.53	29.29	0.05	28.95
Diluted Average Shares	0.59%30.84	30.66	30.51	0.12	29.83
Basic Earnings Per Share	15.14%2.13	1.85	1.91	1.77	2.74
Diluted Earnings Per Share	14.53%2.05	1.79	1.83	1.70	2.66